NSE: KABRADG • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding0.00%
FII Holding0.00%
DII Holding0.00%
Public Holding91.43%
Total Shareholders8,862
As ofDec 2025
View the latest shareholding pattern of Kabra Drugs (KABRADG) including promoter, FII, DII, and public holdings.
Track KABRADG ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal.
(See Kabra Drugs 52-week)
Kabra Drugs (KABRADG) Shareholding Summary
Promoter holding remains unchanged at 0.00% in Dec 2025
FII/FPI holding remains unchanged at 0.00% in Dec 2025
DII holding remains unchanged at 0.00% in Dec 2025
Public holding has decreased from 95.00% to 91.43% in Dec 2025
Number of shareholders increased from 8,098 to 8,862 in Dec 2025
KABRADG Quarterly Ownership Changes
Quarter-over-quarter changes for Kabra Drugs from Sept 2025 to Dec 2025.
Kabra Drugs shareholding pattern reveals who owns KABRADG stock and how ownership changes over time. High promoter stakes in KABRADG often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your KABRADG trades. KABRADG fair value
Combine KABRADG ownership analysis with price movements and financial performance for a complete investment picture. (See KABRADG price earnings ratio)